olaparib
New Indication Granted for Lynparza for BRCA-mutated mCRPC
The FDA granted a new indication for Lynparza with abiraterone and a steroid for adult patients with deleterious or ...
JUNE 2, 2023
Lynparza Approved for Use in HRR-Mutated mCRPC
The FDA approved olaparib (Lynparza, AstraZeneca) for the treatment of adults with deleterious or suspected ...
MAY 28, 2020
Load more